China Shineway Pharmaceutical Group Limited (CSWYF)

USD 1.0

(0.0%)

Market Cap (In USD)

758.42 Million

Revenue (In USD)

4.51 Billion

Net Income (In USD)

137.15 Million

Avg. Volume

3.00

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.9253-1.004
PE
-
EPS
-
Beta Value
0.81
ISIN
KYG2110P1000
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Zhenjiang Li
Employee Count
-
Website
https://www.shineway.com
Ipo Date
2020-02-18
Details
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.